Pluristem Therapeutics (PSTI) Preliminary COVID-19 Results a 'Game Changer' - H.C. Wainwright

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. SBUX
3. NVDA
4. SPCX
5. SPY
6. GOOGL
7. APLD
8. USO
9. STZ
10. AAPL

Go back to Pluristem Therapeutics (PSTI) Preliminary COVID-19 Results a 'Game Changer' - H.C. Wainwright

Pluristem Therapeutics (PSTI) Adds to Recent Gains; Shares up 34%

April 9, 2020 9:31 AM EDT

Pluristem Therapeutics (NASDAQ: PSTI) adds to recent gains on its promising treatment for sick COVID-19 patients. Shares up 34%.

... More

Pluristem Therapeutics (PSTI) Preliminary Data from COVID-19 Compassionate Use Program, Treating Seven Patients with Acute Respiratory Failure

April 7, 2020 7:51 AM EDT

Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: PSTI), a leading regenerative medicine company developing a platform of novel biological therapeutic products, announced today preliminary data from its compassionate use program, treating seven patients suffering from acute respiratory failure and inflammatory complications associated with COVID-19 with Pluristems PLX cells, in three medical centers in... More